Cargando…
Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in RET-Aberrant Digestive Tract Tumours
BACKGROUND: RET plays an oncogenic role, and its aberrations are potentially actionable. However, they have seldom been reported in tumours other than lung or thyroid cancers. The correlation of RET aberrations with clinical characteristics, co-occurring aberrations, and responses to immune checkpoi...
Autores principales: | Yen, Chih-Chieh, Yeh, Yu-Min, Huang, Hsuan-Yi, Ting, Yu-Lin, Fu, Pei-An, Lin, Tzu-Chien, Liu, I-Ting, Yen, Chia-Jui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345067/ https://www.ncbi.nlm.nih.gov/pubmed/37347391 http://dx.doi.org/10.1007/s11523-023-00974-6 |
Ejemplares similares
-
Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies
por: Hegde, Aparna, et al.
Publicado: (2020) -
Hallmarks of RET and Co-occuring Genomic Alterations in RET-aberrant Cancers
por: Adashek, Jacob J., et al.
Publicado: (2021) -
Involvement of RET oncogene in human tumours: specificity of RET activation to thyroid tumours.
por: Santoro, M., et al.
Publicado: (1993) -
Active Smoking Induces Aberrations in Digestive Tract Microbiota of Rats
por: Wang, Xiang, et al.
Publicado: (2021) -
Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022)